Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2011, Article ID 916807, 6 pages
http://dx.doi.org/10.1155/2011/916807
Clinical Study

Serum Adiponectin, Resistin, and Circulating Soluble Receptor for Advanced Glycation End Products in Colectomy Patients

1Spectrum Health Research, Spectrum Health, 25 Michigan Avenue NE, Grand Rapids, MI 49503, USA
2Department of Colorectal Surgery, Spectrum Health, 4100 Lake Drive NE, Suite 205, Grand Rapids, MI 49546, USA
3Laboratory of Microarray Technology, Van Andel Research Institute, 333 Bostwick Avenue NE, Grand Rapids, MI 49503, USA
4Laboratory of Analytical, Cellular, and Molecular Microscopy, Van Andel Research Institute, 333 Bostwick Avenue NE, Grand Rapids, MI 49503, USA
5Division of Colorectal Surgery, Department of Surgery, Keck School of Medicine, USC, 1441 Eastlake Avenue, Suite 7418, Los Angeles, CA 90033-4612, USA

Received 27 May 2011; Accepted 26 June 2011

Academic Editor: Fulvio D'Acquisto

Copyright © 2011 Theodor Asgeirsson et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Sammour, A. Kahokehr, S. Chan, R. J. Booth, and A. G. Hill, “The humoral response after laparoscopic versus open colorectal surgery: a meta-analysis,” Journal of Surgical Research, vol. 164, no. 1, pp. 28–37, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. T. P. Combs, A. H. Berg, S. Obici, P. E. Scherer, and L. Rossetti, “Endogenous glucose production is inhibited by the adipose-derived protein Acrp30,” Journal of Clinical Investigation, vol. 108, no. 12, pp. 1875–1881, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. N. Ouchi, S. Kihara, Y. Arita et al., “Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages,” Circulation, vol. 103, no. 8, pp. 1057–1063, 2001. View at Google Scholar · View at Scopus
  4. T. Yamauchi, J. Kamon, H. Waki et al., “The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity,” Nature Medicine, vol. 7, no. 8, pp. 941–946, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Yamauchi, J. Kamon, Y. Minokoshi et al., “Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase,” Nature Medicine, vol. 8, no. 11, pp. 1288–1295, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Buechler, J. Wanninger, and M. Neumeier, “Adiponectin receptor binding proteins—recent advances in elucidating adiponectin signalling pathways,” FEBS Letters, vol. 584, no. 20, pp. 4280–4286, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. P. Dandona, A. Aljada, and A. Bandyopadhyay, “Inflammation: the link between insulin resistance, obesity and diabetes,” Trends in Immunology, vol. 25, no. 1, pp. 4–7, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. C. M. Steppan, S. T. Bailey, S. Bhat et al., “The hormone resistin links obesity to diabetes,” Nature, vol. 409, no. 6818, pp. 307–312, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Koch, O. A. Gressner, E. Sanson, F. Tacke, and C. Trautwein, “Serum resistin levels in critically ill patients are associated with inflammation, organ dysfunction and metabolism and may predict survival of non-septic patients,” Critical Care, vol. 13, no. 3, article R95, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. G. P. Sims, D. C. Rowe, S. T. Rietdijk, R. Herbst, and A. J. Coyle, “HMGB1 and RAGE in inflammation and cancer,” Annual Review of Immunology, vol. 28, pp. 367–388, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. R. Ramasamy, F. Y. Shi, and A. M. Schmidt, “RAGE: therapeutic target and biomarker of the inflammatory response—the evidence mounts,” Journal of Leukocyte Biology, vol. 86, no. 3, pp. 505–512, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Maillard-Lefebvre, E. Boulanger, M. Daroux, C. Gaxatte, B. I. Hudson, and M. Lambert, “Soluble receptor for advanced glycation end products: a new biomarker in diagnosis and prognosis of chronic inflammatory diseases,” Rheumatology, vol. 48, no. 10, pp. 1190–1196, 2009. View at Google Scholar · View at Scopus
  13. A. Halevy, G. Lin, R. Gold-Deutsch et al., “Comparison of serum C-reactive protein concentrations for laparoscopic versus open cholecystectomy,” Surgical Endoscopy, vol. 9, no. 3, pp. 280–282, 1995. View at Publisher · View at Google Scholar · View at Scopus
  14. G. D. Harmon, A. J. Senagore, M. J. Kilbride, and M. J. Warzynski, “Interleukin-6 response to laparoscopic and open colectomy,” Diseases of the Colon and Rectum, vol. 37, no. 8, pp. 754–759, 1994. View at Publisher · View at Google Scholar · View at Scopus
  15. H. Kehlet, “Multimodal approach to control postoperative pathophysiology and rehabilitation,” British Journal of Anaesthesia, vol. 78, no. 5, pp. 606–617, 1997. View at Google Scholar · View at Scopus
  16. H. Kehlet and D. W. Wilmore, “Multimodal strategies to improve surgical outcome,” American Journal of Surgery, vol. 183, no. 6, pp. 630–641, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Yamamoto, H. Hirose, I. Saito, K. Nishikai, and T. Saruta, “Adiponectin, an adipocyte-derived protein, predicts future insulin resistance: two-year follow-up study in Japanese population,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 1, pp. 87–90, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Fujinami, H. Obayashi, K. Ohta et al., “Enzyme-linked immunosorbent assay for circulating human resistin: resistin concentrations in normal subjects and patients with type 2 diabetes,” Clinica Chimica Acta, vol. 339, no. 1-2, pp. 57–63, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. J. V. Silha, M. Krsek, J. V. Skrha, P. Sucharda, B. L. G. Nyomba, and L. J. Murphy, “Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistence,” European Journal of Endocrinology, vol. 149, no. 4, pp. 331–335, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. P. G. McTernan, F. M. Fisher, G. Valsamakis et al., “Resistin and type 2 diabetes: regulation of resistin expression by insulin and rosiglitazone and the effects of recombinant resistin on lipid and glucose metabolism in human differentiated adipocytes,” Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 12, pp. 6098–6106, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. G. Basta, A. M. Sironi, G. Lazzerini et al., “Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein,” Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 11, pp. 4628–4634, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. A. M. Schmidt, S. D. Yan, S. F. Yan, and D. M. Stern, “The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses,” Journal of Clinical Investigation, vol. 108, no. 7, pp. 949–955, 2001. View at Publisher · View at Google Scholar · View at Scopus